{"id":"W1972313906","doi":"10.1017/s0266462312000499","title":"BENEFITS OF PHARMACEUTICAL INNOVATION: THE CASE OF SIMVASTATIN IN CANADA","year":2012,"lang":"en","type":"review","venue":"International Journal of Technology Assessment in Health Care","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Overtime; Simvastatin; Revenue; Business; Population; Health care; Private sector; Productivity; Medicine; Public economics; Economics; Labour economics; Finance; Economic growth; Environmental health; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001844026,0.00028889,0.0004639983,0.002070681,0.003772074,0.002715803,0.001131444,0.00160864,0.003188503],"category_scores_gemma":[0.008042963,0.0001885837,0.001030036,0.00429998,0.001667338,0.0009449976,0.001522026,0.001637934,0.0001249584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06390323,"about_ca_system_score_gemma":0.05127506,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.988507,"about_ca_topic_score_gemma":0.9905977,"domain_scores_codex":[0.9980642,0.00028438,0.00005219464,0.0001216483,0.000536187,0.0009412555],"domain_scores_gemma":[0.9953898,0.00178016,0.0005849828,0.000138361,0.001320044,0.0007865785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005808681,0.000324261,0.6000315,0.0003531463,0.000333846,0.007549832,0.005463006,0.08107521,0.0008046416,0.2097404,0.01531705,0.07842629],"study_design_scores_gemma":[0.0002550942,0.0001986839,0.6735082,0.0005037542,0.0005464421,0.002203971,0.02039324,0.1835939,0.0006444596,0.06090171,0.05698663,0.0002639628],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9107928,0.004719951,0.00295351,0.02112343,0.00005432189,0.0002047514,0.002508024,0.00003147387,0.0576118],"genre_scores_gemma":[0.9926298,0.00120172,0.001258554,0.0003822848,0.00002296357,0.00002324685,0.0002554904,0.000006014666,0.004219887],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.06390323,"threshold_uncertainty_score":0.4636526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1391712358686328,"score_gpt":0.4498081869635117,"score_spread":0.3106369510948789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}